← Back to Clinical Trials
RecruitingNCT00001160

Studies on Tumors of the Thyroid

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionHurthle Cell Thyroid Cancer
SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment2,500
SexALL
Min Age6 Months
Max Age98 Years
Start Date1977-06-01
CompletionN/A
Interventions
68-Gallium Dotatate

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies.

Eligibility Criteria

* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Male or female, adults or children \>= 6 months+. 2. Patients with known or suspected thyroid nodules and/or thyroid cancer. 3. At risk family members of patients who have a genetic susceptibility to developing thyroid cancer. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1\. Serious underlying medical conditions that restrict diagnostic testing or therapy such as renal failure, congestive cardiac failure or active coexisting non-thyroid carcinoma requiring intervention before thyroid cancer is addressed.

Related Trials